Cosgrove Kelly P, McKay Reese, Esterlis Irina, Kloczynski Tracy, Perkins Evgenia, Bois Frederic, Pittman Brian, Lancaster Jack, Glahn David C, O'Malley Stephanie, Carson Richard E, Krystal John H
Departments of Psychiatry and Clinical Neuroscience Division, VA National Center for PTSD, VA Connecticut Healthcare System, West Haven, CT 06516; National Institute on Alcohol Abuse and Alcoholism Center for the Translational Neuroscience of Alcoholism, New Haven, CT 06510; Neurobiology, and Department of Diagnostic Radiology, Yale PET Center, Yale University School of Medicine, New Haven, CT 06510;
Departments of Psychiatry and Olin Neuropsychiatric Research Center, Institute of Living, Hartford, CT 06114; and.
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):18031-6. doi: 10.1073/pnas.1413947111. Epub 2014 Dec 1.
Understanding the effects of tobacco smoking on neuroadaptations in GABAA receptor levels over alcohol withdrawal will provide critical insights for the treatment of comorbid alcohol and nicotine dependence. We conducted parallel studies in human subjects and nonhuman primates to investigate the differential effects of tobacco smoking and nicotine on changes in GABAA receptor availability during acute and prolonged alcohol withdrawal. We report that alcohol withdrawal with or without concurrent tobacco smoking/nicotine consumption resulted in significant and robust elevations in GABAA receptor levels over the first week of withdrawal. Over prolonged withdrawal, GABAA receptors returned to control levels in alcohol-dependent nonsmokers, but alcohol-dependent smokers had significant and sustained elevations in GABAA receptors that were associated with craving for alcohol and cigarettes. In nonhuman primates, GABAA receptor levels normalized by 1 mo of abstinence in both groups--that is, those that consumed alcohol alone or the combination of alcohol and nicotine. These data suggest that constituents in tobacco smoke other than nicotine block the recovery of GABAA receptor systems during sustained alcohol abstinence, contributing to alcohol relapse and the perpetuation of smoking.
了解吸烟对酒精戒断期间GABAA受体水平神经适应性的影响,将为治疗酒精和尼古丁共病依赖提供关键见解。我们在人类受试者和非人类灵长类动物中进行了平行研究,以调查吸烟和尼古丁对急性和长期酒精戒断期间GABAA受体可用性变化的不同影响。我们报告称,无论是否同时吸烟/摄入尼古丁,在戒断的第一周,酒精戒断都会导致GABAA受体水平显著且强劲升高。在长期戒断过程中,酒精依赖的非吸烟者的GABAA受体恢复到对照水平,但酒精依赖的吸烟者的GABAA受体有显著且持续的升高,这与对酒精和香烟的渴望有关。在非人类灵长类动物中,两组(即单独饮酒组或同时饮酒和尼古丁组)在戒酒1个月后GABAA受体水平均恢复正常。这些数据表明,除尼古丁外,烟草烟雾中的成分会在持续戒酒期间阻碍GABAA受体系统的恢复,导致酒精复吸和吸烟持续存在。